MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 6.000
- +0.466+8.41%
Close Dec 20 16:00 ET
- 5.990
- -0.010-0.17%
Post 20:01 ET
56.35MMarket Cap-100.00P/E (TTM)
6.000High5.600Low22.82KVolume5.600Open5.534Pre Close130.68KTurnover0.66%Turnover RatioLossP/E (Static)9.39MShares22.82552wk High-4.09P/B20.91MFloat Cap3.81052wk Low--Dividend TTM3.48MShs Float209.262Historical High--Div YieldTTM7.23%Amplitude3.810Historical Low5.726Avg Price1Lot Size
Serina Therapeutics News
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory
Serina Therapeutics | 8-K: Current report
Serina Therapeutics | 8-K: Current report
Serina Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Juvenescence Limited(42.0%),JuvVentures (UK) Limited(41.3%)
Serina Therapeutics | 8-K: Current report
Serina Therapeutics | 424B3: Prospectus
Serina Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Broadwood Partners, L.P.(2.1%),Broadwood Capital, Inc.(2.1%), etc.
Serina Therapeutics | 8-K: Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Serina Therapeutics | 10-Q: Quarterly report
Serina Therapeutics | ARS: Annual Report to Security Holders
Serina Therapeutics | DEFA14A: Others
Serina Therapeutics | DEF 14A: Definitive information statements
Serina Therapeutics | DEFC14A: Others
Serina Therapeutics | 8-K: Current report
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bailey Gregory
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MINTZ STEVEN
Serina Therapeutics | 8-K: Current report
Serina Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEDGER STEVEN A
Serina Therapeutics | 8-K: Current report
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.